From:  Peptide treatment of human plasma disrupts metabolic and age-related pathologies via heat shock protein 70

 Statistics for fructosamine measurements.

ComparisonsSamplesMean diff.95.00% CI of diff.Adjusted p-value
no MG vs. MG9 vs. 9–51.16–58.93 to –43.39< 0.0001
no MG vs. 0 µM-MG9 vs. 6–49.03–57.71 to –40.34< 0.0001
no MG vs. 1 µM-MG9 vs. 6–53.13–61.81 to –44.44< 0.0001
no MG vs. 10 µM-MG9 vs. 6–53.02–61.70 to –44.33< 0.0001

MG: methylglyoxal; diff.: difference.